Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Assessment of Infectious Diseases and Immune Mediated Disorders After BCG (re)Vaccination

NCT05387655 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05387655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05387655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Assessment of Infectious Diseases and Immune Mediated Disorders After BCG (re)Vaccination
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
May 20, 2022
Completion date
June 20, 2027
Enrollment
4,292 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcg vaccination reaction, covid-19, infections, inflammation